Displaying 265 - 276 of 492
Metabolism, Alcohol & Toxicity

Approaching MASH as a metabolic disease to reduce outcomes

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel Discussion (Q & A)

Webcasts
View
Liver Tumours

Introduction

Webcasts
View
Liver Tumours

General Overview on liver imaging, when do we need MRI? Benefits of liver-specific agents

Webcasts
View
Liver Tumours

Imaging of HCC, results of the SORAMIC trial and treatment stratification in HCC

Webcasts
View
Liver Tumours

Q&A

Webcasts
View
Liver Tumours

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver ...

Webcasts
View
Liver Tumours

Clinical impact of non-arterial enhancing lesions in patients at risk of HCC - therapy and follow-up

Webcasts
View
Viral Hepatitis
Gilead: Q the Experts on HDV

Gilead: Q the Experts on HDV

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Addressing NASH as a chronic metabolic disease: the need for a simplified patient referral pathway

Webcasts
View
Displaying 265 - 276 of 492